Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 1475 entries
View as:

Study of BMS-650032 With Peginterferon Alfa-2a Plus Ribavirin

Phase: N/A Priority: Normal
NCT ID: NCT01030432 Org: User:
Start: 02/28/10 End: 10/31/12 Due: 10/31/13

A Study to Determine the Effect of Famotidine on the Drug Levels of BMS-986256 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04941755 Org: User:
Start: 06/25/21 End: 09/24/21 Due: 09/24/22

A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart

Phase: N/A Priority: Normal
NCT ID: NCT02415400 Org: User:
Start: 06/04/15 End: 11/10/18 Due: 11/10/19

Phase IV, Open-label, Multicenter Study of Dasatinib in Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients With Chronic, Low-grade Non-Hematologic Toxicity to Imatinib

Phase: N/A Priority: Normal
NCT ID: NCT01660906 Org: User:
Start: 12/31/12 End: 10/31/15 Due: 10/31/16

Diclofenac 25mg/Paracetamol 500 mg and Diclofenac 50 mg/Paracetamol 500 mg for Patients With Pain

Phase: N/A Priority: Normal
NCT ID: NCT02651363 Org: User:
Start: 03/31/16 End: 09/30/16 Due: 09/30/17

Three-year Follow-up Study of Subjects Who Participated in a Previous Lambda (BMS-914143) Chronic Hepatitis C Clinical Trial

Phase: N/A Priority: Normal
NCT ID: NCT01525810 Org: User:
Start: 03/31/12 End: 11/30/14 Due: 11/30/15

Local Adaptation of Cost Effectiveness Model for Apixaban Atrial Fibrillation Indication - Venezuela

Phase: N/A Priority: Normal
NCT ID: NCT02756481 Org: User:
Start: 10/31/13 End: 11/30/14 Due: 11/30/15

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Phase: N/A Priority: Normal
NCT ID: NCT01361555 Org: User:
Start: 08/31/11 End: 10/31/13 Due: 10/31/14

A Study of BMS-224818 (Belatacept) in Patients Who Have Undergone a Kidney Transplant and Are Currently on Stable Cyclosporine or Tacrolimus Regimen With or Without Corticosteroids

Phase: N/A Priority: Normal
NCT ID: NCT00402168 Org: User:
Start: 01/31/07 End: 06/30/13 Due: 06/30/14

A Study to Document Long-Term Safety and Continued Benefit of Irinotecan and Carboplatin or Irinotecan in Subjects With Refractory Solid Tumors (Rollover Study -001, -002)

Phase: N/A Priority: Normal
NCT ID: NCT00990912 Org: User:
Start: 01/31/04 End: 11/30/05 Due: 11/30/06

The Study of Abatacept in Combination With Etanercept

Phase: N/A Priority: Normal
NCT ID: NCT00162279 Org: User:
Start: 10/31/00 End: 02/28/07 Due: 02/28/08

An Investigational Study of NKTR-214 Combined With Nivolumab in Japanese Participants With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03745807 Org: User:
Start: 04/09/19 End: 12/18/19 Due: 12/18/20

A Study Comparing the Efficacy and Safety of Nivolumab in Combination With Bacillus Calmette-Guerin (BCG) Versus BCG Alone in Participants With High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC)

Phase: N/A Priority: Normal
NCT ID: NCT04149574 Org: User:
Start: 01/15/20 End: 10/31/23 Due: 10/31/24

An Exploratory Study of the Effects of Nivolumab Combined With Ipilimumab in Patients With Treatment-Naive Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT03001882 Org: User:
Start: 03/29/17 End: 04/24/23 Due: 04/24/24

Safety Study of Abatacept in Rheumatoid Arthritis Participants

Phase: N/A Priority: Normal
NCT ID: NCT03696173 Org: User:
Start: 12/17/15 End: 06/29/18 Due: 06/29/19

Advanced Chronic Myelogenous Leukemia (CML) - Follow On: Study of BMS-354825 in Subjects With CML

Phase: N/A Priority: Normal
NCT ID: NCT00123487 Org: User:
Start: 06/30/05 End: 06/30/13 Due: 06/30/14

A Phase I Study to Determine the Effect of Food on Brivanib (BMS-582664)

Phase: N/A Priority: Normal
NCT ID: NCT00437437 Org: User:
Start: 05/31/00 End: 02/28/13 Due: 02/28/14

A Study to Evaluate the Drug Levels of BMS-986165 When Taken as Various Solid Tablet Prototypes by Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04536961 Org: User:
Start: 09/10/20 End: 12/25/20 Due: 12/25/21

A Study of Neoadjuvant Nivolumab + Palbociclib + Anastrozole in Post-Menopausal Women and Men With Primary Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04075604 Org: User:
Start: 10/18/19 End: 07/27/21 Due: 07/27/22

A Study of BMS-986205 Alone and in Combination With Nivolumab in Chinese Patients With Advanced Malignant Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03792750 Org: User:
Start: 12/31/18 End: 12/18/20 Due: 12/18/21

An Investigational Study of Experimental Medication BMS-986231 Given in Participants With Different Levels of Liver Function

Phase: N/A Priority: Normal
NCT ID: NCT03515980 Org: User:
Start: 05/25/18 End: 08/29/19 Due: 08/29/20

Safety Study of Nivolumab to Treat Advanced or Metastatic Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03090737 Org: User:
Start: 06/02/17 End: 03/14/22 Due: 03/14/23

Study With Healthy Japanese and Non-Asian Participants With BMS-986231

Phase: N/A Priority: Normal
NCT ID: NCT02932969 Org: User:
Start: 10/04/16 End: 05/26/17 Due: 05/26/18

A Clinical Study Evaluating Nivolumab-containing Treatments in Patients With Advanced Non-small Cell Lung Cancer After Failing Previous PD-1/(L)1 Therapy and Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT04151563 Org: User:
Start: 04/15/21 End: 05/13/26 Due: 05/13/27

Elotuzumab Safety Surveillance In Japanese Patients With Relapse Or Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT02976493 Org: User:
Start: 01/01/18 End: 06/18/18 Due: 06/18/19